3.40p-0.05 (-1.45%)20 May 2022, 16:15
Jump to:
Omega Diagnostics Group PLC Fundamentals
Company Name | Omega Diagnostics Group PLC | Last Updated | 2022-05-20 |
---|---|---|---|
Industry | Medical Instruments & Supplies | Sector | Healthcare |
Shares in Issue | 232.682 m | Market Cap | £7.91 m |
PE Ratio | 0.00 | Dividend per Share | 0 |
Dividend Yield | 0 | Dividend Cover | 0 |
EPS | -£0.01 | EPS Growth (%) | 0 |
PEG | 0 | DPS Growth (%) | 0 |
Debt Ratio | 0.0918 | Debt Equity Ratio | 0.1117 |
Asset Equity Ratio | 1.4045 | Cash Equity Ratio | 0.2283 |
Quick Ratio | 1.5640 | Current Ratio | 2.04 |
Price To Book Value | 0.3845 | ROCE | 0 |
Omega Diagnostics Group PLC Dividends
Type | Ex-Date | Pay Date | Currency | Net Dividend | Year Total |
---|
Omega Diagnostics Group PLC Company Financials
Assets | 2021 | 2020 | 2019 |
---|---|---|---|
Tangible Assets | £4.88 m | £3.16 m | £1.57 m |
Intangible Assets | £10.18 m | £9.68 m | £17.04 m |
Investments | 0 | 0 | 0 |
Total Fixed Assets | £18.75 m | £14.38 m | £19.99 m |
Stocks | £2.24 m | £1.17 m | £1.00 m |
Debtors | £4.04 m | £3.19 m | £2.31 m |
Cash & Equivalents | £5.83 m | 0 | 0 |
Other Assets | 0 | 0 | 0 |
Total Assets | £30.99 m | £18.84 m | £23.48 m |
Liabilities | 2021 | 2020 | 2019 |
---|---|---|---|
Creditors within 1 year | £3.55 m | £2.34 m | £2.31 m |
Creditors after 1 year | £3.76 m | £2.89 m | £2.98 m |
Other Liabilities | 0 | 0 | 0 |
Total Liabilities | £7.32 m | £5.23 m | £5.28 m |
Net assets | £23.67 m | £13.61 m | £18.19 m |
Equity | 2021 | 2020 | 2019 |
---|---|---|---|
Called up share capital | £33.32 m | £22.01 m | £19.80 m |
Share Premium | 0 | 0 | 0 |
Profit / Loss | -£3.54 m | -£8.30 m | -£368,417.00 |
Other Equity | £23.67 m | £13.61 m | £18.19 m |
Preference & Minorities | 0 | 0 | 0 |
Total Capital Employed | £23.67 m | £13.61 m | £18.19 m |
Ratios | 2021 | 2020 | 2019 |
---|---|---|---|
Debt Ratio | £0.09 | £0.12 | £0.00 |
Debt-to-Equity | £0.10 | £0.13 | £0.00 |
Assets / Equity | 1.4045 | 1.4045 | 1.4045 |
Cash / Equity | 0.2283 | 0.2283 | 0.2283 |
EPS | -£0.01 | £0.00 | £-0.00 |
Cash Flow | 2021 | 2020 | 2019 |
---|---|---|---|
Cash from operating activities | -£2.42 m | £547,607.00 | £368,819.00 |
Cashflow before financing | £8.65 m | £2.18 m | £903,789.00 |
Increase in Cash | £5.83 m | £29,814.00 | £9,324.00 |
Income | 2021 | 2020 | 2019 |
---|---|---|---|
Turnover | £8.73 m | £9.82 m | £8.76 m |
Cost of sales | £4.28 m | £3.52 m | £3.12 m |
Gross Profit | £4.46 m | £6.29 m | £5.63 m |
Operating Profit | 0 | 0 | -£271,343.00 |
Pre-Tax profit | -£3.54 m | -£8.30 m | -£368,417.00 |
Omega Diagnostics Group PLC Company Background
Sector | Healthcare |
---|---|
Activities | Omega Diagnostics Group PLC provides in-vitro diagnostics (IVD) products for use in hospitals, blood banks, clinics and laboratories and specializes in the areas of allergy and autoimmune, food intolerance and infectious diseases. The company's segment includes Health and Nutrition; Global Health and Other. It generates maximum revenue from the Health and Nutrition segment. The Health and Nutrition division specialises in the research, development, and production of kits to aid the detection of immune reactions to food. Geographically, it derives a majority of revenue from Asia and the Far East region. |
Latest Interim Date | 25 Nov 2021 |
Latest Fiscal Year End Date | 13 Jul 2021 |
Omega Diagnostics Group PLC Directors
Appointed | Name | Position |
---|---|---|
2012-07-11 | Mr. Geoff Gower | Executive Director |
2021-07-13 | Mr. Kieron Antony Harbinson | Executive Director,Finance Director and Company Secretary |
2013-07-01 | Mr. Michael Stephen Gurner | Non-Executive Director |
2019-10-01 | Mr. David Eric Evans | Non-Executive Director,Chairman |
2018-08-15 | Mr. Andrew William Shepherd | Executive Director,Chief Executive Officer |
2008-06-05 | Dr. Michael Strachan Walker, B.Sc. ,PhD | Non-Executive Director |
2021-07-30 | Mr. Jagdeep Grewal | Executive Director,Chief Executive Officer |
2022-01-19 | Mr. William E. Rhodes III | Non-Executive Director |
2021-07-30 | Mr. Jeremy Howard Millard | Non-Executive Director |
2022-01-19 | Mr. Colin King | Executive Director,Chief Executive Officer |
2021-07-30 | Dr. Simon Gordon Douglas | Non-Executive Director,Chairman |
Omega Diagnostics Group PLC Contact Details
Company Name | Omega Diagnostics Group PLC |
---|---|
Address | One Fleet Place, London, EC4M 7WS |
Telephone | +44 1259763030 |
Website | https://www.omegadiagnostics.com |
Omega Diagnostics Group PLC Advisors
Auditor | EY |
---|
Bank | National Westminster Bank PLC |
---|
Stockbroker | FinnCap |
---|---|
Phone | +44 2072200500 |
Fax | +44 2076001659 |
Financial PR Adviser | Walbrook PR |
---|---|
Phone | +44 2079338780 |
Fax | +44 2079338781 |
Registrar | Share Registrars Limited |
---|---|
Phone | +44 1252821390 |
Fax | +44 1252719232 |
Solicitor | Brodies LLP |
---|---|
Phone | (0131) 228 3777 |
Fax | (0131) 228 3878 |
Nominated Adviser | FinnCap |
---|---|
Phone | +44 2072200500 |
Fax | +44 2076001659 |
Sign up to our
daily email
Subscribe to the latest investing news by entering your email address below
You can opt out at any time.
For five days a week you will get
- The latest company news
- Insight into investment trends
- Round-up of director's buys and sells
- Articles from Shares magazine

Plus more useful investment content and occasional promotional offers.
Market Overview
UK 350 Risers and Fallers
Risers
Company | Price | % Chg |
---|---|---|
Countryside Partnerships PLC | 243.00 | 6.86 |
Darktrace PLC | 363.10 | 6.79 |
Playtech PLC | 539.00 | 6.73 |
Royal Mail PLC | 315.40 | 5.13 |
Bridgepoint Group PLC | 285.00 | 4.47 |
Genus PLC | 2,684.00 | 4.03 |
Fallers
Company | Price | % Chg |
---|---|---|
Discoverie Group PLC | 710.00 | -4.05 |
Coats Group PLC | 75.40 | -3.83 |
Tui AG | 201.50 | -3.68 |
Baillie Gifford Us Growth Trust PLC | 155.00 | -3.13 |
Auction Technology Group PLC | 903.00 | -3.11 |
Scottish Mortgage Investment Trust PLC | 737.00 | -3.03 |